What is your preferred third antimicrobial agent for a patient with treatment-naive pulmonary MAC without cavitary disease and strict contraindications to utilization of rifampin or rifabutin?
Answer from: at Community Practice
Typically, I would choose a third agent in addition to a macrolide and ethambutol such as moxifloxacin or thrice weekly amikacin.
Sign in or Register to read more
Answer from: at Community Practice
If there is no macrolide resistance I would cautiously try 2 drug rx. There is a study going on now at Stanford and UCSF, and possibly others looking at this.